サイクリン依存性キナーゼ9の世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Cyclin Dependent Kinase 9 Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21JY00001)・商品コード:GIR21JY00001
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年7月
・ページ数:96
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥455,880見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥683,820見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥911,760見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、サイクリン依存性キナーゼ9の世界市場を広く調査・分析し、今後の市場展望をまとめております。サイクリン依存性キナーゼ9の種類別市場規模(LY-2857785、CYC-065、BAY-1251152、AZD-4573、TP-1287、その他)、用途別市場規模(マントル細胞リンパ腫、胃がん、炎症、喉頭がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Astex Pharmaceuticals Inc、AstraZeneca Plc、Bayer AG、Cyclacel Pharmaceuticals Inc、Eli Lilly and Company、Jyant Technologies Inc、Selvita SA、Tolero Pharmaceuticals Inc、Tragara Pharmaceuticals Inc、Vichem Chemie Research Ltd、ViroStatics srl
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:LY-2857785、CYC-065、BAY-1251152、AZD-4573、TP-1287、その他
・用途別分析2016年-2026年:マントル細胞リンパ腫、胃がん、炎症、喉頭がん、その他
・サイクリン依存性キナーゼ9の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・サイクリン依存性キナーゼ9のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・サイクリン依存性キナーゼ9のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・サイクリン依存性キナーゼ9の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・サイクリン依存性キナーゼ9の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Cyclin Dependent Kinase 9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cyclin Dependent Kinase 9 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cyclin Dependent Kinase 9 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cyclin Dependent Kinase 9 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
LY-2857785
CYC-065
BAY-1251152
AZD-4573
TP-1287
Others

Market segment by Application can be divided into
Mantle Cell Lymphocytic
Gastric Cancer
Inflammation
Laryngeal Cancer
Others

The key market players for global Cyclin Dependent Kinase 9 market are listed below:
Astex Pharmaceuticals Inc
AstraZeneca Plc
Bayer AG
Cyclacel Pharmaceuticals Inc
Eli Lilly and Company
Jyant Technologies Inc
Selvita SA
Tolero Pharmaceuticals Inc
Tragara Pharmaceuticals Inc
Vichem Chemie Research Ltd
ViroStatics srl

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cyclin Dependent Kinase 9 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cyclin Dependent Kinase 9, with price, sales, revenue and global market share of Cyclin Dependent Kinase 9 from 2019 to 2021.
Chapter 3, the Cyclin Dependent Kinase 9 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclin Dependent Kinase 9 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cyclin Dependent Kinase 9 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cyclin Dependent Kinase 9 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Cyclin Dependent Kinase 9 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cyclin Dependent Kinase 9 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 LY-2857785
1.2.3 CYC-065
1.2.4 BAY-1251152
1.2.5 AZD-4573
1.2.6 TP-1287
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cyclin Dependent Kinase 9 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Mantle Cell Lymphocytic
1.3.3 Gastric Cancer
1.3.4 Inflammation
1.3.5 Laryngeal Cancer
1.3.6 Others
1.4 Global Cyclin Dependent Kinase 9 Market Size & Forecast
1.4.1 Global Cyclin Dependent Kinase 9 Sales in Value (2016-2026))
1.4.2 Global Cyclin Dependent Kinase 9 Sales in Volume (2016-2026)
1.4.3 Global Cyclin Dependent Kinase 9 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Cyclin Dependent Kinase 9 Production Capacity Analysis
1.5.1 Global Cyclin Dependent Kinase 9 Total Production Capacity (2016-2026)
1.5.2 Global Cyclin Dependent Kinase 9 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cyclin Dependent Kinase 9 Market Drivers
1.6.2 Cyclin Dependent Kinase 9 Market Restraints
1.6.3 Cyclin Dependent Kinase 9 Trends Analysis
2 Manufacturers Profiles
2.1 Astex Pharmaceuticals Inc
2.1.1 Astex Pharmaceuticals Inc Details
2.1.2 Astex Pharmaceuticals Inc Major Business
2.1.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
2.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc Cyclin Dependent Kinase 9 Product and Services
2.2.4 AstraZeneca Plc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Cyclin Dependent Kinase 9 Product and Services
2.3.4 Bayer AG Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cyclacel Pharmaceuticals Inc
2.4.1 Cyclacel Pharmaceuticals Inc Details
2.4.2 Cyclacel Pharmaceuticals Inc Major Business
2.4.3 Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
2.4.4 Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Cyclin Dependent Kinase 9 Product and Services
2.5.4 Eli Lilly and Company Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Jyant Technologies Inc
2.6.1 Jyant Technologies Inc Details
2.6.2 Jyant Technologies Inc Major Business
2.6.3 Jyant Technologies Inc Cyclin Dependent Kinase 9 Product and Services
2.6.4 Jyant Technologies Inc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Selvita SA
2.7.1 Selvita SA Details
2.7.2 Selvita SA Major Business
2.7.3 Selvita SA Cyclin Dependent Kinase 9 Product and Services
2.7.4 Selvita SA Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Tolero Pharmaceuticals Inc
2.8.1 Tolero Pharmaceuticals Inc Details
2.8.2 Tolero Pharmaceuticals Inc Major Business
2.8.3 Tolero Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
2.8.4 Tolero Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Tragara Pharmaceuticals Inc
2.9.1 Tragara Pharmaceuticals Inc Details
2.9.2 Tragara Pharmaceuticals Inc Major Business
2.9.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
2.9.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Vichem Chemie Research Ltd
2.10.1 Vichem Chemie Research Ltd Details
2.10.2 Vichem Chemie Research Ltd Major Business
2.10.3 Vichem Chemie Research Ltd Cyclin Dependent Kinase 9 Product and Services
2.10.4 Vichem Chemie Research Ltd Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 ViroStatics srl
2.11.1 ViroStatics srl Details
2.11.2 ViroStatics srl Major Business
2.11.3 ViroStatics srl Cyclin Dependent Kinase 9 Product and Services
2.11.4 ViroStatics srl Cyclin Dependent Kinase 9 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cyclin Dependent Kinase 9 Sales by Manufacturer
3.1 Global Cyclin Dependent Kinase 9 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cyclin Dependent Kinase 9 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cyclin Dependent Kinase 9
3.4 Market Concentration Rate
3.4.1 Top 3 Cyclin Dependent Kinase 9 Manufacturer Market Share
3.4.2 Top 6 Cyclin Dependent Kinase 9 Manufacturer Market Share
3.5 Global Cyclin Dependent Kinase 9 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cyclin Dependent Kinase 9 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cyclin Dependent Kinase 9 Market Size by Region
4.1.1 Global Cyclin Dependent Kinase 9 Sales in Volume by Region (2016-2026)
4.1.2 Global Cyclin Dependent Kinase 9 Revenue by Region (2016-2026)
4.2 North America Cyclin Dependent Kinase 9 Revenue (2016-2026)
4.3 Europe Cyclin Dependent Kinase 9 Revenue (2016-2026)
4.4 Asia-Pacific Cyclin Dependent Kinase 9 Revenue (2016-2026)
4.5 South America Cyclin Dependent Kinase 9 Revenue (2016-2026)
4.6 Middle East and Africa Cyclin Dependent Kinase 9 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cyclin Dependent Kinase 9 Sales in Volume by Type (2016-2026)
5.2 Global Cyclin Dependent Kinase 9 Revenue by Type (2016-2026)
5.3 Global Cyclin Dependent Kinase 9 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cyclin Dependent Kinase 9 Sales in Volume by Application (2016-2026)
6.2 Global Cyclin Dependent Kinase 9 Revenue by Application (2016-2026)
6.3 Global Cyclin Dependent Kinase 9 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cyclin Dependent Kinase 9 Sales by Type (2016-2026)
7.2 North America Cyclin Dependent Kinase 9 Sales by Application (2016-2026)
7.3 North America Cyclin Dependent Kinase 9 Market Size by Country
7.3.1 North America Cyclin Dependent Kinase 9 Sales in Volume by Country (2016-2026)
7.3.2 North America Cyclin Dependent Kinase 9 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cyclin Dependent Kinase 9 Sales by Type (2016-2026)
8.2 Europe Cyclin Dependent Kinase 9 Sales by Application (2016-2026)
8.3 Europe Cyclin Dependent Kinase 9 Market Size by Country
8.3.1 Europe Cyclin Dependent Kinase 9 Sales in Volume by Country (2016-2026)
8.3.2 Europe Cyclin Dependent Kinase 9 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cyclin Dependent Kinase 9 Sales by Type (2016-2026)
9.2 Asia-Pacific Cyclin Dependent Kinase 9 Sales by Application (2016-2026)
9.3 Asia-Pacific Cyclin Dependent Kinase 9 Market Size by Region
9.3.1 Asia-Pacific Cyclin Dependent Kinase 9 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cyclin Dependent Kinase 9 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cyclin Dependent Kinase 9 Sales by Type (2016-2026)
10.2 South America Cyclin Dependent Kinase 9 Sales by Application (2016-2026)
10.3 South America Cyclin Dependent Kinase 9 Market Size by Country
10.3.1 South America Cyclin Dependent Kinase 9 Sales in Volume by Country (2016-2026)
10.3.2 South America Cyclin Dependent Kinase 9 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cyclin Dependent Kinase 9 Sales by Type (2016-2026)
11.2 Middle East & Africa Cyclin Dependent Kinase 9 Sales by Application (2016-2026)
11.3 Middle East & Africa Cyclin Dependent Kinase 9 Market Size by Country
11.3.1 Middle East & Africa Cyclin Dependent Kinase 9 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cyclin Dependent Kinase 9 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cyclin Dependent Kinase 9 Typical Distributors
12.3 Cyclin Dependent Kinase 9 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Cyclin Dependent Kinase 9 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cyclin Dependent Kinase 9 Revenue by Application, (USD Million), 2021-2026
Table 3. Astex Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Astex Pharmaceuticals Inc Major Business
Table 5. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
Table 6. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Major Business
Table 9. AstraZeneca Plc Cyclin Dependent Kinase 9 Product and Services
Table 10. AstraZeneca Plc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Major Business
Table 13. Bayer AG Cyclin Dependent Kinase 9 Product and Services
Table 14. Bayer AG Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cyclacel Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 16. Cyclacel Pharmaceuticals Inc Major Business
Table 17. Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
Table 18. Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company Cyclin Dependent Kinase 9 Product and Services
Table 22. Eli Lilly and Company Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Jyant Technologies Inc Basic Information, Manufacturing Base and Competitors
Table 24. Jyant Technologies Inc Major Business
Table 25. Jyant Technologies Inc Cyclin Dependent Kinase 9 Product and Services
Table 26. Jyant Technologies Inc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Selvita SA Basic Information, Manufacturing Base and Competitors
Table 28. Selvita SA Major Business
Table 29. Selvita SA Cyclin Dependent Kinase 9 Product and Services
Table 30. Selvita SA Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Tolero Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Tolero Pharmaceuticals Inc Major Business
Table 33. Tolero Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
Table 34. Tolero Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Tragara Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 36. Tragara Pharmaceuticals Inc Major Business
Table 37. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 9 Product and Services
Table 38. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vichem Chemie Research Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Vichem Chemie Research Ltd Major Business
Table 41. Vichem Chemie Research Ltd Cyclin Dependent Kinase 9 Product and Services
Table 42. Vichem Chemie Research Ltd Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. ViroStatics srl Basic Information, Manufacturing Base and Competitors
Table 44. ViroStatics srl Major Business
Table 45. ViroStatics srl Cyclin Dependent Kinase 9 Product and Services
Table 46. ViroStatics srl Cyclin Dependent Kinase 9 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Cyclin Dependent Kinase 9 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Cyclin Dependent Kinase 9 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Cyclin Dependent Kinase 9, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Cyclin Dependent Kinase 9 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Cyclin Dependent Kinase 9 Production Site of Key Manufacturer
Table 52. Cyclin Dependent Kinase 9 New Entrant and Capacity Expansion Plans
Table 53. Cyclin Dependent Kinase 9 Mergers & Acquisitions in the Past Five Years
Table 54. Global Cyclin Dependent Kinase 9 Sales by Region (2016-2021e) & (K Pcs)
Table 55. Global Cyclin Dependent Kinase 9 Sales by Region (2021-2026) & (K Pcs)
Table 56. Global Cyclin Dependent Kinase 9 Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Cyclin Dependent Kinase 9 Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 59. Global Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 60. Global Cyclin Dependent Kinase 9 Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Cyclin Dependent Kinase 9 Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Cyclin Dependent Kinase 9 Price by Type (2016-2021e) & (USD/Pcs)
Table 63. Global Cyclin Dependent Kinase 9 Price by Type (2021-2026) & (USD/Pcs)
Table 64. Global Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 65. Global Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 66. Global Cyclin Dependent Kinase 9 Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Cyclin Dependent Kinase 9 Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Cyclin Dependent Kinase 9 Price by Application (2016-2021e) & (USD/Pcs)
Table 69. Global Cyclin Dependent Kinase 9 Price by Application (2021-2026) & (USD/Pcs)
Table 70. North America Cyclin Dependent Kinase 9 Sales by Country (2016-2021e) & (K Pcs)
Table 71. North America Cyclin Dependent Kinase 9 Sales by Country (2021-2026) & (K Pcs)
Table 72. North America Cyclin Dependent Kinase 9 Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Cyclin Dependent Kinase 9 Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 75. North America Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 76. North America Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 77. North America Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 78. Europe Cyclin Dependent Kinase 9 Sales by Country (2016-2021e) & (K Pcs)
Table 79. Europe Cyclin Dependent Kinase 9 Sales by Country (2021-2026) & (K Pcs)
Table 80. Europe Cyclin Dependent Kinase 9 Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Cyclin Dependent Kinase 9 Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 83. Europe Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 84. Europe Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 85. Europe Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Region (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Region (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Cyclin Dependent Kinase 9 Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Cyclin Dependent Kinase 9 Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 93. Asia-Pacific Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 94. South America Cyclin Dependent Kinase 9 Sales by Country (2016-2021e) & (K Pcs)
Table 95. South America Cyclin Dependent Kinase 9 Sales by Country (2021-2026) & (K Pcs)
Table 96. South America Cyclin Dependent Kinase 9 Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Cyclin Dependent Kinase 9 Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 99. South America Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 100. South America Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 101. South America Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Country (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Country (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Cyclin Dependent Kinase 9 Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Cyclin Dependent Kinase 9 Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Type (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Type (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Application (2016-2021e) & (K Pcs)
Table 109. Middle East & Africa Cyclin Dependent Kinase 9 Sales by Application (2021-2026) & (K Pcs)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Cyclin Dependent Kinase 9 Typical Distributors
Table 113. Cyclin Dependent Kinase 9 Typical Customers
List of Figures
Figure 1. Cyclin Dependent Kinase 9 Picture
Figure 2. Global Cyclin Dependent Kinase 9 Sales Market Share by Type in 2020
Figure 3. LY-2857785
Figure 4. CYC-065
Figure 5. BAY-1251152
Figure 6. AZD-4573
Figure 7. TP-1287
Figure 8. Others
Figure 9. Global Cyclin Dependent Kinase 9 Sales Market Share by Application in 2020
Figure 10. Mantle Cell Lymphocytic
Figure 11. Gastric Cancer
Figure 12. Inflammation
Figure 13. Laryngeal Cancer
Figure 14. Others
Figure 15. Global Cyclin Dependent Kinase 9 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Cyclin Dependent Kinase 9 Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Cyclin Dependent Kinase 9 Sales (2016-2026) & (K Pcs)
Figure 18. Global Cyclin Dependent Kinase 9 Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Cyclin Dependent Kinase 9 Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Cyclin Dependent Kinase 9 Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Cyclin Dependent Kinase 9 Market Drivers
Figure 22. Cyclin Dependent Kinase 9 Market Restraints
Figure 23. Cyclin Dependent Kinase 9 Market Trends
Figure 24. Global Cyclin Dependent Kinase 9 Sales Market Share by Manufacturer in 2020
Figure 25. Global Cyclin Dependent Kinase 9 Revenue Market Share by Manufacturer in 2020
Figure 26. Cyclin Dependent Kinase 9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Cyclin Dependent Kinase 9 Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Cyclin Dependent Kinase 9 Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Cyclin Dependent Kinase 9 Sales Market Share by Region (2016-2026)
Figure 30. Global Cyclin Dependent Kinase 9 Revenue Market Share by Region (2016-2026)
Figure 31. North America Cyclin Dependent Kinase 9 Revenue (2016-2026) & (USD Million)
Figure 32. Europe Cyclin Dependent Kinase 9 Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Cyclin Dependent Kinase 9 Revenue (2016-2026) & (USD Million)
Figure 34. South America Cyclin Dependent Kinase 9 Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Cyclin Dependent Kinase 9 Revenue (2016-2026) & (USD Million)
Figure 36. Global Cyclin Dependent Kinase 9 Sales Market Share by Type (2016-2026)
Figure 37. Global Cyclin Dependent Kinase 9 Revenue Market Share by Type (2016-2026)
Figure 38. Global Cyclin Dependent Kinase 9 Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 40. Global Cyclin Dependent Kinase 9 Revenue Market Share by Application (2016-2026)
Figure 41. Global Cyclin Dependent Kinase 9 Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Cyclin Dependent Kinase 9 Sales Market Share by Type (2016-2026)
Figure 43. North America Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 44. North America Cyclin Dependent Kinase 9 Sales Market Share by Country (2016-2026)
Figure 45. North America Cyclin Dependent Kinase 9 Revenue Market Share by Country (2016-2026)
Figure 46. United States Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Cyclin Dependent Kinase 9 Sales Market Share by Type (2016-2026)
Figure 50. Europe Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 51. Europe Cyclin Dependent Kinase 9 Sales Market Share by Country (2016-2026)
Figure 52. Europe Cyclin Dependent Kinase 9 Revenue Market Share by Country (2016-2026)
Figure 53. Germany Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Cyclin Dependent Kinase 9 Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Cyclin Dependent Kinase 9 Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Cyclin Dependent Kinase 9 Revenue Market Share by Region (2016-2026)
Figure 62. China Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Cyclin Dependent Kinase 9 Sales Market Share by Type (2016-2026)
Figure 69. South America Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 70. South America Cyclin Dependent Kinase 9 Sales Market Share by Country (2016-2026)
Figure 71. South America Cyclin Dependent Kinase 9 Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Cyclin Dependent Kinase 9 Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Cyclin Dependent Kinase 9 Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Cyclin Dependent Kinase 9 Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Cyclin Dependent Kinase 9 Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Cyclin Dependent Kinase 9 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


【掲載企業】

Astex Pharmaceuticals Inc、AstraZeneca Plc、Bayer AG、Cyclacel Pharmaceuticals Inc、Eli Lilly and Company、Jyant Technologies Inc、Selvita SA、Tolero Pharmaceuticals Inc、Tragara Pharmaceuticals Inc、Vichem Chemie Research Ltd、ViroStatics srl

★調査レポート[サイクリン依存性キナーゼ9の世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21JY00001)販売に関する免責事項を必ずご確認ください。
★調査レポート[サイクリン依存性キナーゼ9の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆